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INTRODUCTION
The rat remnant kidney model, usually involving the
removal or ablation of 1-1/2 to 1-5/6 of renal mass, has
been widely used to investigate mechanisms of renal
injury and principles derived from this model have
been applied to human renal research. The rat model
initially results in compensatory hypertrophy of the
residual normal renal tissue. This is followed by the
development of hypertension, proteinuria, and gradu-
ally declining glomerular filtration rate (GFR) associ-
ated with focal and then global glomerular sclerosis
and progressive tubular and interstitial injury, eventu-
ally culminating in the animal’s death in advanced
uremia (1-3). These processes are associated with in-
creased glomerular capillary pressures and flows (1,
4), thought to be pathogenetically important since
manipulation of these variables by reduction in pro-
tein intake (1, 5) or anti-hypertensive therapy (6) is 
associated with reduction in the rate of injury in this
model. Compensatory glomerular hypertrophy may
also be important, since, in a model manipulated to
prevent this glomerular enlargement, glomerular cap-
illary hyperfiltration and hypertension alone were in-
sufficient to induce this renal injury process (3). A
possible limitation in the remnant kidney model as a
representation of human renal injury is that clinical
renal disease in humans rarely results from the sud-
den loss of the large majority of renal mass. Rather,
most human renal diseases are characterized by more
gradual loss of functioning renal tissue. The current
study tested the hypothesis that a more gradual reduc-
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ABSTRACT: Background: The remnant kidney model, usually involving sudden removal or ablation of 1- 1/2 to 1-5/6 of
renal mass, results in compensatory hypertrophy followed by hypertension, proteinuria and declining glomerular fil-
tration rate (GFR) associated with focal (FSG) and then global glomerulosclerosis (GS) and tubulointerstitial injury
(TI).  Since most renal diseases involve much more gradual injury, we asked whether slow ablation (SA) produced a
different natural history than fast ablation (FA).
Methods: Male Münich-Wistar rats underwent heminephrectomy, 3 weeks later a second, and 3 weeks later a third hem-
inephrectomy (SA).  They were compared to littermates undergoing simultaneous removal of 1- 1/2 kidneys (FA) and
sham operated controls (C).
Results: Three weeks after the second heminephrectomy, the SA rats had no FSG and glomerular volume (GV) was
similar to that of FA rat renal tissue removed at that time. Eight weeks following the final surgical procedure (FSP),
the SA and FA groups had similar blood pressures (BP) but higher than C. Albumin excretion rates (AER) were high-
er in SA and FA vs. C at 1 month after the FSP and, throughout most of the subsequent 5 months, greater in the SA
vs. FA groups. At 24 weeks, cortical interstitial fractional volume was double C values in both the SA and FA groups.
Percentage of glomeruli with FSG and size (score) of FSG lesions was much higher in SA and FA than C. Moreover,
the percentage of FSG in SA (61.2±16%) and FSG score (1.7±0.7) was greater than in FA animals (35.6±11.9% and
0.9±0.4, p<0.01 for each comparison). Mean GV, increased at 24 weeks in both groups over C (1.4±0.2 X 106 µm3) was
greater in SA (3.4±0.7 X 106 µm3) than FA rats (2.1±0.4 X 106 µm3; p<0.005).
Conclusions: The gradual uninephrectomy in the SA group, insufficient per se to produce significant renal damage, pre-
conditioned the residual kidney, upon further removal of another 1/2 kidney, to more albuminuria and FSG lesions
than occurred following sudden 1- 1/2 nephrectomy, despite similarly elevated BP. Perhaps more time for glomerular
enlargement in the SA group preconditioned the remnant kidney to accelerated injury.
Key words: Rats, Remnant kidney model
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tion in functioning renal mass in rats could result in a
different natural history in the rat remnant kidney
model.
MATERIALS AND METHODS
Male Münich-Wistar rats (Bioproducts Division, Har-
lan Sprague-Dawley, Madison, WI) weighing 250
grams at the start of the experiments were randomly
allocated into 3 groups.
Slow ablation (SA) group. Gradual renal mass reduc-
tion: Rats had an initial heminephrectomy under gen-
eral anesthesia. Through a left flank incision, the mass
of the left kidney was reduced by approximately one
half by removal of the upper and lower poles of the
left kidney. In preliminary studies performed on 3
rats, we confirmed using the Cavalieri method (7)
that, in fact, about half of the renal mass and cortex
was removed using this method. Three weeks later, the
remainder of this kidney was removed through a mid-
line incision. Three weeks later, in a final surgical pro-
cedure (FSP), a contralateral right heminephrectomy
was performed as described above through a right
flank incision. Duration in the SA group was timed
from the day of this final surgical procedure.
Fast ablation (FA) group. Sudden renal mass reduc-
tion: Rats had sham operations performed at the
times of the first 2 procedures in the SA group. Sham
operations were carried out by exposing the appropri-
ate kidney and removing the renal capsule. At the ini-
tial sham operation, the left kidney was exposed and
renal capsule was removed. At the second sham oper-
ation, the left kidney was again exposed and scar tis-
sues removed from renal surface. Three weeks later
these rats underwent a 1-1/2 nephrectomy on the day
of the FSP in the SA group.
In order to evaluate renal structure at the time of the
FSP, 6 additional Münich-Wistar rats (the SA group)
underwent heminephrectomy. Three weeks later, the
remainder of this kidney was removed and 3 weeks lat-
er the contralateral kidney tissue was obtained for
morphologic study. Another 6 rats (the FA group) had
sham operations performed at the times of the first 2
procedures in the SA group. Three weeks later, con-
tralateral kidney tissue was obtained for morphologic
study.
Control group. Control rats underwent sham opera-
tions at the times described above for the FA group. At
the third sham operation, the right kidney was ex-
posed and its capsule removed. After the surgeries, all
rats were allowed free access to water and Purina lab
chow diet.
Functional studies. After the FSP, blood pressure,
serum creatinine, hematocrit and 24-hour urinary al-
bumin excretion rates (AER) were measured every 3
weeks until 20 weeks after the final surgical procedure.
Systolic BP was measured in awake rats by tail-cuff
method using a Gilson photoelectric rat tail pulse pick
up transducer (model T-4021) connected with an
adapter (model A-4023) to IC-MP channel #1 and
pressure transducer (model P23XL, Spectramed, Ox-
nard, CA, USA) to IC-MP channel #2 (Gilson Biophys-
ical Duograph, ICT-2H Duograph, two IC-MP chan-
nel, Gilson Medical Electronics, Middleton, WI, USA).
An average of 3 - 4 measurements for each rat were 
obtained during the study and on the day of glomeru-
lar filtration rate (GFR) study (see below). The tail BP
measured on the day of GFR study was highly correlat-
ed with femoral mean arterial blood pressure that was
obtained during the GFR study (8).
Serum creatinine was measured by the Jaffé rate
method using the Beckman Creatinine Analyzer 2
(Beckman Instruments, Inc., Fullerton, CA, USA).
All rats were placed individually in metabolic cages for
24-hour urine collections to measure AER. Urine 
albumin concentration was measured with a laser
nephelometer (Hyland, Deerfield, IL, USA) using a
monoclonal antibody against rat serum albumin (Cap-
pel Laboratories, West Chester, PA, USA).
Twenty-four weeks after the FSP, GFR and arterial BP
measurements were obtained. On the day of these
studies, rats were anesthetized with an intraperitoneal
injection of Inactin (80 -100mg/Kg) and placed on a
temperature regulated table to maintain a rectal tem-
perature of 37°C. A tracheostomy was performed by
inserting PE-240 tubing via the same surgical field as
for the isolation of the jugular vein. PE-50 catheters
were placed in the left femoral artery for blood sam-
pling and BP monitoring using a Spectramed physio-
logical pressure transducer (model P23XL, Spec-
tramed, Oxnard, CA, USA) connected to the Gilson
Biophysical Duograph. Arterial blood samples (200µl)
were obtained at the beginning of the experiment and
at the mid-point of each clearance period for the mea-
surement of hematocrit and plasma Iothalamate con-
centrations.
A double lumen catheter with PE-50 tubing was insert-
ed into left external jugular vein for infusion of 5%
B.S.A. at 0.5% of body weight (BW) in a period of 20
minutes during the surgery, followed by a constant 
infusion rate of 0.6ml/hr per rat. A bolus of 0.5cc of
sodium Iothalamate 125 I in isotonic saline solution
was infused over 10 minutes via the second lumen fol-
lowed by a constant infusion rate of 0.8ml/hr for the
remainder of the study. The range of radioactive io-
dine activity infused was predetermined in each group
of rats in order to achieve a plasma level of approxi-
mately 1000 counts per min/ml, and 5 and 7mCi/ml of
sodium Iothalamate 125 I were infused (9).
The bladder was cannulated (using PE-50 tubing) di-
rectly through a small suprapubic incision in order to
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obtain a urine sample for each clearance period. After
a 30-minute equilibration period, 2-3 clearance peri-
ods of 20 minutes each were obtained.
I-125 counts were determined using a Gamma 400
counting system counter (Beckman Scientific Instru-
ment Division, Irvine, CA, USA). The GFR was calcu-
lated by the formula: GFR (ml/min) = (Urine CPM x
Urine volume/20min)/Arterial CPM and expressed
as ml/min/Kg where CPM=counts per minute (9).
After the GFR study was completed, a PE-50 polyethyl-
ene catheter pre-filled with Millonig’s buffer was 
inserted into the aorta and advanced to the level of
the aortic bifurcation. The perfusate was infused at a
pressure equivalent to the individual rat’s mean arter-
ial pressure (MAP). The pressure of the perfusate was
monitored with a Spectramed physiological pressure
transducer (model P23XL). The kidneys were per-
fused until completely blanched with 1% glutaralde-
hyde in Millonig’s buffer for 2 min. The renal tissue
was then removed and left overnight in the same fixa-
tive and processed for embedding (10).
MORPHOLOGIC STUDIES
To estimate kidney volume (KV) and cortical volume,
each kidney was cut into 2mm slices. The Cavalieri
method was used to estimate kidney volume, volume
fraction (Vv) of kidney which is cortex (C) (Vv C/K)
on these slices (7). Renal slices were embedded in
paraffin, and serially sectioned at 4µm. Sections were
stained with periodic acid-Schiff (PAS) and examined
for the volume fraction of cortex which is glomerulus
(Vv G/C) (11), volume fraction of cortex which is 
interstitium (I) (Vv I/C) (12), frequency (%) of
glomeruli with focal segmental glomerulosclerosis
(FSG) lesions and the size (score) of FSG (see below).
Total glomerular volume in an animal was calculated
from the kidney volume, Vv(C/K) and Vv(G/C) using
the formula:
Total glomerular volume per animal = 
Kidney volume x Vv(C/K) x Vv(G/C) (11)
Mean glomerular volume (GV) was measured at an
approximate magnification of X110 using the point-
counting method of Weibel and Gomez (13). Twenty-
two to 41 (median 29) glomerular profiles per animal
were measured.
All the glomeruli present on one slide from each ex-
perimental rat were examined to estimate the fre-
quency (%) and score of FSG in the study groups. The
number of glomeruli examined per rat was 170±53 
(X
–
± SD) in SA group and 151±32 in the FA group.
One hundred glomeruli were examined in the control
group. FSG was recognized as an increase of mesan-
gial matrix substance associated with capillary wall
wrinkling and collapse. These sclerotic lesions were
not always associated with adhesions to Bowman’s cap-
sule. Hyalinosis was defined by the presence of PAS-
positive hyalin material included in or separated by
sclerotic regions in the subendothelium or in the
mesangium (15).
The severity of FSG in a given tissue specimen was 
assessed by assigning a score of 1+ to 4+ to each
glomerulus according to the proportion of the tuft
demonstrating FSG: normal glomerulus, 0; up to 25%
involvement, 1+; 25% to 50% involvement, 2+; 50% to
75% involvement, 3+; and more than 75% involve-
ment, 4+. The FSG score for each tissue specimen was
the sum of individual glomerular scores multiplied by
the percent of glomeruli with the same score:
4
FSG Score = ∑i(ni/n)100
i=0
where ni is the number of glomeruli in the tissue spec-
imen with FSG score i, and n is the total number of
glomeruli in the sample (15).
Statistics
Data from multiple groups were compared using
ANOVA followed by paired two-sided Student's t-tests.
Repeated measures of ANOVA and regression analysis
were used to compare the 24-hour UAE between the
SA and FA groups from 2 weeks to 20 weeks after FSP
and the slopes of the UAE regression lines were com-
pared. Values of p<0.05 were considered significant.
RESULTS
Functional studies
Blood pressure
The SA group initially consisted of 12 rats, with 13 rats
in the FA group, and 12 rats in the control group.
There were no significant group differences in systolic
BP by the tail method at the time of the first three sur-
gical procedures. However, from the 8th week after
the FSP, systolic BP in the SA and FA groups were sig-
nificantly higher than in the control group (p<0.05)
for each comparison (Fig. 1). There were, however, no
significant differences in BP between the SA and FA
groups. The increasing BP in the SA and FA groups
appeared to level off by the 11th week when they were
150±15 and 157±16 mmHg, respectively and at 20
weeks after FSP these BPs were about 17-24mmHg
higher than controls (Fig. 1).
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Serum creatinine
Serum creatinine levels in the SA and FA groups were
higher than in the control group from the 2nd week
onwards (p<0.001) for each comparison (Fig. 2).
There were no differences between the SA and FA
groups during the 20 week period after the FSP except
for the 2nd week when the serum creatinine levels
were higher in the FA group (p<0.01) (Fig. 2).
Albumin excretion rate
AER after the FSP was consistently higher in the SA
and FA groups than in controls, (p<0.0005 for each
comparison, Fig. 3). Repeated measures of ANOVA
was used to compare the AER between the SA and FA
groups from weeks 2 to 20 after the FSP. But for the
5th and 20th weeks, there was a significant difference
between the two groups (p<0.01) indicating that the
increase in AER in the SA group was greater, indepen-
dent of the effects of time on AER. Also, the slopes of
the regression lines of AER and time were different
for the SA (y=17.2x 8.2) vs. FA (y=10.5x 0.7;
p<0.001) groups.
Final kidney function studies
Eight of 12 SA group rats survived to 24 weeks after
the FSP. However 2 of these animals were very sick on
the day of final renal function studies. Thus 6 rats were
included for the final GFR and morphologic studies.
Ten of the initial 13 FA group rats survived and were
included in these final studies. While 11 control rats
survived, 7 were randomly selected for functional and
morphological study, since this number was consid-
ered to be sufficient.
The GFR at 24 weeks after FSP was lower in the SA and
FA groups than in the control group (p<0.001 both
comparisons) (Tab. I). There was no difference in 
final GFR between the SA and FA groups.
The values for mean intra-arterial pressure (MAP) at
24 weeks paralleled values for systolic BP by the tail
method in awake animals. MAP was 44-50 mmHg
higher in the SA and FA groups vs. controls but was
not different in the SA vs. FA groups (Tab. I). 
Hematocrits at sacrifice were lower in the SA and FA
groups (34.5±2.4% and 37±3.6%, respectively) than in the
control group (47.6±1.6%; p<0.001, both comparisons).
Hematocrits in the SA and FA groups did not differ.
Fig. 1 - The course of systolic blood pressure after the final
surgical procedure (FSP) in the three groups of rats. Blood
pressure was measured by tail method. Data are X
–
± SD.
*P=<0.05 vs. slow and fast ablation groups.
Fig. 2 - The course of serum creatinine after the final surgical
procedure in the three groups of rats. *P=<0.001 vs. slow and
fast ablation groups. **P=<0.01 vs. slow ablation group.
Fig. 3 - The course of 24-hour urinary albumin excretion rate
(AER) after the final surgical procedure (FSP) in the three
groups of rats. *P=<0.005 vs. slow and fast ablation groups.
**P=0.01 vs. fast ablation group.
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Kidney structural studies
There were no FSG lesions in either the SA or FA
groups at the time of the final FSP. Further, GV in the
SA group (0.65±0.6 x 106 µm3) and FA group
(0.61±0.04 x 106 µm3) were not significantly different
at this time. The total kidney volume per animal at the
end of the study as measured by the Cavalieri method
was closely correlated with the kidney weight (y=0.94x
+ 0.28, r=0.95). There was no significant difference be-
tween the SA and FA groups in final kidney weight
(Tab. II). Total kidney weight in the control group ex-
ceeded those in either the SA or FA groups (Tab. II).
Kidney weight in the SA was higher than the weight of
a single kidney in the control group (p<0.05), but
there was no difference in this comparison between
the FA and control groups.
There were no significant differences in Vv C/K be-
tween groups (Tab. II). The cortical interstitial vol-
ume fraction (Vv I/C) was much higher in both the
SA and FA groups than in the control group. There
was no significant difference, however, between the
two ablated groups (Tab. II). The volume fraction of
cortex which is glomerulus (Vv G/C) and the total GV
per animal were decreased in both the ablated groups
compared to the control group (Tab. II). There was
no difference in total GV per animal between the SA
and FA groups. However, at 24 weeks after the FSP the
mean GV was greater in the SA group than in the FA
group and was greater in both ablated groups com-
pared to the control group (Tab. II).
The frequency (%) of FSG lesions at 24 weeks was
higher in both the SA and FA groups than in the con-
trol group. The frequency (%) and the size (score) of
FSG lesions were also higher in the SA than in the FA
group (Tab. II).
DISCUSSION
The remnant kidney model in rats has been widely used
to investigate mechanisms involved in the progression
of renal disease. In this model, nephron number is sud-
denly reduced by surgical ablation or infarction of kid-
ney tissue. Initially, normal remnant nephrons develop
injury at rates which depend on the method of ablation
(16), the amount of renal tissue removed, and the
strain and sex of rats being used (17).
However, the sudden decrease in the functioning kid-
ney tissue by removal and/or destruction of 1-1/2 or
more of the animal’s kidney tissue is unlike most renal
diseases in humans, which are characterized by the
much more gradual loss of functioning renal tissue.
This study compared the structural and functional
TABLE I - FINAL RENAL FUNCTION DATA
GFR AER Mean arterial BP
(ml/min/Kg) (mg/24hr) (mmHg)
SA group 1.1±0.8 322.8±164.2 186.0±22.0
FA group 1.0±0.4 196.9±97.4 179.8±17.6
Control group 6.6±1.3* 7.3±5.3* 136.3±10.9*
*p<0.001 vs. SA and FA groups
Abbreviations: SA=slow ablation; FA=fast ablation; GFR=glomerular filtration rate; BP=blood pressure; AER=albumin excretion rate.
TABLE II - RENAL STRUCTURAL DATA AT 24 WEEKS AFTER FINAL SURGICAL PROCEDURE
Total Vv(Cortex/ Vv(Intersti- Vv(Glomerulus/ Total Mean Frequency Size
kidney kidney) tium/cortex) cortex) glomerular glomerular (%) of FSG (Score)
weight volume per volume of FSG
per animal animal (ml) (x 106 µm3)
(gram)
SA group 2.45±0.43 0.69±0.02 23.5±3.8 0.04±0.01 0.07±0.02 3.4±0.7** 61.2±16.0* 1.7±0.7**
FA group 2.21±0.47 0.68±0.03 22.0±3.7 0.04±0.01 0.05±0.01 2.1±0.4 35.6±11.9 0.9±0.4
Control group 4.04±0.40a 0.66±0.01 10.2±1.2a 0.05±0.003b 0.12±0.01a 1.4±0.2b 0.6±1.1a 0.01±0.02a
*p<0.01, **p<0.005 vs. FA group
ap<0.001 vs. SA and FA groups
bp<0.005 vs. SA and FA groups.
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manifestations of the remnant kidney model in rats
subjected to gradual vs. sudden reduction in renal
mass. Moreover, most studies of this model have not
followed the animals long enough to characterize the
ultimate progressive reduction in GFR and the associ-
ated structural changes.
An important consideration in the design of these
studies is that the standard ablation model of unilater-
al nephrectomy and infarction of a large segment of
the contralateral kidney (by occluding branches of the
renal artery) results in a marginal infarct zones which
produces increased local renal renin production and
marked hypertension (18). Surgical subtotal nephrec-
tomy was used in our study in order to more closely
mimic the course of most human renal diseases which
typically are unassociated with severe hypertension
early in the course of injury. In fact, the BP in the FA
and SA groups were normal during the first 5 weeks 
after the final surgical procedure, leveled off by 11
weeks and remained stable thereafter.
It is possible that the systemic hypertension in SA and
FA animals promoted the development of albumin-
uria and FSG lesions, perhaps by contributing to
glomerular capillary hypertension (1). However, be-
cause systemic BP, estimated by either the tail cuff
method or by direct intrarterial measurement, was
similar in the SA and FA groups, this variable cannot
easily explain why SA animals had more albuminuria
following the FSP and more FSG lesions at the end of
the experiment. However, it is not possible to exclude
greater glomerular capillary hypertension in the SA
group as the cause of their greater AER and FSG le-
sions, since these measurements were not done.
Nonetheless, elevated glomerular capillary pressure
and blood flow alone may not fully explain the albu-
minuria and FSG lesions which develop in rats with re-
duced functioning renal mass. In fact, rats subjected
to 2/3 infarction of one kidney with contralateral 
intraperitoneal ureteral drainage (effectively remov-
ing the clearance function of this second kidney) de-
velop glomerular capillary hypertension, no glomeru-
lar hypertrophy and no FSG lesions (3). This was in
contrast to rats subjected to uninephrectomy and 2/3
infarction of the other kidney where glomerular hy-
pertrophy together with equivalent levels of glomeru-
lar capillary hypertension was associated with severe
FSG lesions (3).
Our studies eliminated the possibility that the increase
in FSG lesions in the SA vs. the FA rats represented the
addition of FSG lesions present at the time of the FSP
to lesions developing subsequent to the FSP. It should
be recalled that the SA animals were first subjected to
a heminephrectomy and, 3 weeks later, to removal of
the rest of that kidney, completing a uninephrectomy.
Three weeks later, at the time of the FSP, FSG lesions
were not detected in either the SA or FA groups and
there was no significant difference in GV between
these groups. The study by Hostetter et al (19), also
did not detect an increase over controls in FSG lesions
4 months after uninephrectomy in Münich-Wistar
rats.
It is possible that the greater glomerular volume seen
in the SA vs. FA animals at sacrifice in our studies 
resulted from the longer time available for compen-
satory glomerular hypertrophy to occur in the SA rats.
Alternatively, the worse FSG lesions in the SA animals
could have stimulated greater compensatory glomeru-
lar hypertrophy in these rats, perhaps contributing to
further glomerular injury. The mechanism whereby
glomerular hypertrophy alone or in concert with
glomerular hemodynamic perturbations could lead to
albuminuria and FSG lesions is unknown, but there is
support for the notion that the glomerular visceral ep-
ithelial cells may not proliferate in response to the in-
creased surface they must cover with glomerular vol-
ume increase, and this may lead to their detachment
and adhesion to parietal epithelial cells initiating the
FSG lesion and proteinuria (20).
It is also possible that the increased albuminuria in the
SA rats in the 24 weeks after the FSP contributed to
the increase in FSG lesions in these rats. However, 
Nagase analbuminemic rats have similar severity of
FSG lesions compared to Sprague-Dawley rats given
Adriamycin, despite marked differences in protein-
uria between the two groups (21).
Tubulointerstitial injury may contribute to the loss of
remnant nephron function (22). Both the SA and FA
groups had Vv(Interstitium/cortex) values more than
twice the values for controls. Multiple studies suggest
that proteinuria could lead to tubular and interstitial
injury (23, 24), and the extent of tubular, interstitial
and glomerular injury are correlated with protein ex-
cretion rates in rats with renal ablation (16). In this
context, it is unclear why SA rats, with greater AER for
several months and greater FSG lesions at sacrifice,
had no greater increase in Vv(Interstitium/cortex)
than FA rats. 
It is reasonable to assume that the greater serum crea-
tinine in FA vs. SA groups 2 weeks after the FSP, oc-
curred because the SA group had time for compen-
satory adaptation, since at 5 weeks after FSP, serum
creatinine in the FA group had decreased and, there-
after, there were no serum creatinine differences be-
tween the SA and FA groups. Moreover, the GFRs were
not different between these groups at 24 weeks after
the FSP.
In summary, these studies demonstrate that removal
of renal mass in a quantity and for an insufficient time
to, per se, produce detectable glomerular injury, pre-
conditions the residual nephrons for accelerated in-
jury upon further loss of renal mass. The study did not
provide a clear explanation for the mechanism of this
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acceleration. Nonetheless, if early losses in nephron
mass can predispose to accelerated residual nephron
injury with further nephron mass reduction, this
would suggest that intervention strategies might be
beneficial earlier in the course of many progressive 
renal diseases, perhaps even before any renal func-
tional disturbances such as albuminuria, hypertension
or decline in GFR are detectable.
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